Clinical Trial Update: Montelukast With Status Asthmaticus, Ages 2-5 [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes Montelukast being studied in young children with status asthmaticus and asthma across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Status Asthmaticus

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Status Asthmaticus, Asthma | Phase 2, Phase 3 | Status: UNKNOWN